Search News
| 71.10 Delayed Data As of Sep 21 |  +0.32 / +0.45%Today’s Change | 52.83 Today|||52-Week Range 71.58 | +26.36% Year-to-Date |
| Previous close | 70.78 |
| Today’s open | 70.91 |
| Day’s range | 70.91 - 71.58 |
| Volume | 17,033,118 |
| Average volume (3 months) | 8,784,193 |
| Market cap | $189.1B |
| Earnings growth (last year) | -38.30% |
| Earnings growth (this year) | +7.43% |
| Earnings growth (next 5 years) | +7.11% |
| Revenue growth (last year) | +1.23% |
| P/E ratio | 142.2 |
| Price/Sales | 3.87 |
| Price/Book | 5.58 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.51 | -0.59% |
| ABBVAbbVie | -0.42 | -0.45% |
| ABTAbbott Laboratories | +0.26 | +0.38% |
| PFEPfizer | +0.31 | +0.71% |
| Next reporting date | October 25, 2018 |
| EPS forecast (this quarter) | $1.12 |
| Annual revenue (last year) | $40.0B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 5.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
